AP2014007564A0 - Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt therefor - Google Patents

Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt therefor

Info

Publication number: AP2014007564A0
Authority: AP; ARIPO
Prior art keywords: quinolin; thiophen; piperazin; benzo; butoxy
Prior art date: 2011-10-14

Application number

AP2014007564A

Other languages

English (en)

Inventor

Yoshiharu Inoue

Original Assignee

Otsuka Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-10-14

Filing date

2012-10-12

Publication date

2014-04-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48081918&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2014007564(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2012-10-12 Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd

2014-04-30 Publication of AP2014007564A0 publication Critical patent/AP2014007564A0/xx

Links

ZKIAIYBUSXZPLP-UHFFFAOYSA-N brexpiprazole Chemical compound C1=C2NC(=O)C=CC2=CC=C1OCCCCN(CC1)CCN1C1=CC=CC2=C1C=CS2 ZKIAIYBUSXZPLP-UHFFFAOYSA-N 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2813—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Inorganic Chemistry (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Supply Of Fluid Materials To The Packaging Location (AREA)
Basic Packing Technique (AREA)

AP2014007564A 2011-10-14 2012-10-12 Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt therefor AP2014007564A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2011227057		2011-10-14
PCT/JP2012/076415 WO2013054872A1 (ja)	2011-10-14	2012-10-12	７－［４－（４－ベンゾ［ｂ］チオフェン－４－イル－ピペラジン－１－イル）ブトキシ］－１Ｈ－キノリン－２－オン又はその塩を含む錠剤

Publications (1)

Publication Number	Publication Date
AP2014007564A0 true AP2014007564A0 (en)	2014-04-30

Family

ID=48081918

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2014007564A AP2014007564A0 (en)	2011-10-14	2012-10-12	Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt therefor

Country Status (34)

Country	Link
US (8)	US20140234417A1 (es)
EP (1)	EP2767285B2 (es)
JP (2)	JP6084161B2 (es)
KR (1)	KR102072371B1 (es)
CN (2)	CN103889425B (es)
AP (1)	AP2014007564A0 (es)
AR (1)	AR088319A1 (es)
AU (1)	AU2012321723C1 (es)
BR (1)	BR112014008603A2 (es)
CA (1)	CA2851588C (es)
CL (1)	CL2014000909A1 (es)
CO (1)	CO6950480A2 (es)
CY (1)	CY1122460T1 (es)
DK (1)	DK2767285T4 (es)
EA (1)	EA032930B1 (es)
ES (1)	ES2762479T5 (es)
FI (1)	FI2767285T4 (es)
HR (1)	HRP20200037T4 (es)
HU (1)	HUE047493T2 (es)
IL (1)	IL231513B (es)
IN (1)	IN2014DN02055A (es)
JO (1)	JO3753B1 (es)
LT (1)	LT2767285T (es)
MX (1)	MX376092B (es)
MY (1)	MY173370A (es)
PH (1)	PH12014500607A1 (es)
PL (1)	PL2767285T5 (es)
PT (1)	PT2767285T (es)
SG (2)	SG2014013783A (es)
SI (1)	SI2767285T2 (es)
TW (1)	TWI634908B (es)
UA (1)	UA114411C2 (es)
WO (1)	WO2013054872A1 (es)
ZA (1)	ZA201402333B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI320783B (en)	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
JO3753B1 (ar) *	2011-10-14	2021-01-31	Otsuka Pharma Co Ltd	قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
JOP20200109A1 (ar)	2012-04-23	2017-06-16	Otsuka Pharma Co Ltd	مستحضر قابل للحقن
JP5936732B1 (ja) *	2015-03-05	2016-06-22	日本カラコン合同会社	フィルムコーティング組成物
CN105106142B (zh) *	2015-09-22	2018-05-22	成都欣捷高新技术开发有限公司	一种含有依匹哌唑的冻干口服制剂及其制备方法
CN106994119A (zh) *	2016-01-22	2017-08-01	浙江华海药业股份有限公司	含有依匹哌唑或其盐的口腔崩解片及其制备方法
CA3014090A1 (en) *	2016-02-19	2017-08-24	Jiangsu Hengrui Medicine Co., Ltd.	Pharmaceutical composition containing jak kinase inhibitor or pharmaceutically acceptable salt thereof
KR20190022709A (ko) *	2016-06-28	2019-03-06	가부시키가이샤 니폰 고킨 소고 겐큐쇼	부형제 및 정제
CN109475557B (zh) *	2016-07-27	2022-01-07	日本脏器制药株式会社	含有甲氨蝶呤的薄膜包衣片
US11123300B2 (en) *	2016-08-16	2021-09-21	Hexal Ag	Immediate release tablet of a benzothiophene compound
US20200093821A1 (en)	2016-08-16	2020-03-26	Hexal Ag	Pharmaceutical Compositions of a Benzothiophene Compound
CN106496206A (zh) *	2016-08-31	2017-03-15	安徽省润生医药股份有限公司	一种依匹哌唑新的制备方法
JP7053645B2 (ja) *	2017-02-23	2022-04-12	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	化合物ｉｉｉの新しい医学的使用
JP7166754B2 (ja) *	2017-11-22	2022-11-08	沢井製薬株式会社	ダサチニブ無水物含有製剤
EP3501506B1 (en)	2017-12-19	2019-10-09	Alfred E. Tiefenbacher (GmbH & Co. KG)	Pharmaceutical tablet composition comprising brexpiprazole
EP3545950A1 (en)	2018-03-26	2019-10-02	Adamed sp. z o.o.	Pharmaceutical composition comprising brexpiprazole
JPWO2021029020A1 (es) *	2019-08-13	2021-02-18
WO2021095092A1 (ja) *	2019-11-11	2021-05-20	大塚製薬株式会社	口腔内崩壊錠
CN112168794A (zh) *	2020-10-27	2021-01-05	浙江诺得药业有限公司	一种布瑞哌唑片的制备方法
WO2022218358A1 (zh) *	2021-04-13	2022-10-20	上海博志研新药物技术有限公司	一种布瑞哌唑物口腔薄膜剂、其制备方法及应用
EP4374856A1 (en)	2022-11-23	2024-05-29	Sanovel Ilac Sanayi Ve Ticaret A.S.	A process for tablets comprising brexpiprazole

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562375B1 (en) *	1999-08-04	2003-05-13	Yamanouchi Pharmaceuticals, Co., Ltd.	Stable pharmaceutical composition for oral use
AU2002353659A1 (en) *	2001-12-18	2003-07-15	Synthon B.V.	Simvastatin dosage forms
AU2003223093B2 (en) *	2002-05-03	2010-02-04	Israel Institute For Biological Research	Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
OA13050A (en)	2003-04-29	2006-11-10	Pfizer Ltd	5,7-diaminopyrazolo [4,3-D] pyrimidines useful in the treatment of hypertension.
CN100480279C (zh) *	2003-06-09	2009-04-22	陶氏环球技术公司	稳定的有机硼烷聚合反应引发剂和可聚合的组合物
JP2006061067A (ja) *	2004-08-26	2006-03-09	Asahi Kasei Life & Living Corp	酸素インジケーター
GB0504203D0 (en) *	2005-03-01	2005-04-06	Novartis Ag	Organic compounds
EP2783688A1 (en)	2005-03-17	2014-10-01	Synhton B.V.	Pharmaceutical tablets of crystalline type ii aripiprazole
JP4315393B2 (ja)	2005-04-14	2009-08-19	大塚製薬株式会社	複素環化合物
TWI320783B (en) *	2005-04-14	2010-02-21	Otsuka Pharma Co Ltd	Heterocyclic compound
DE602006004694D1 (de)	2006-01-05	2009-02-26	Teva Pharma	Feuchtgranulierungsmethode zur Herstellung pharmazeutischer Aripiprazolzusammensetzungen
JP4806595B2 (ja) *	2006-07-05	2011-11-02	富士フイルム株式会社	固体撮像素子駆動装置及びデジタルカメラ
JP4540700B2 (ja) *	2006-10-13	2010-09-08	大塚製薬株式会社	医薬
WO2008106059A1 (en) *	2007-02-26	2008-09-04	Merck & Co., Inc.	Formulations for cathepsin k inhibitors
JP5432720B2 (ja) *	2007-03-13	2014-03-05	武田薬品工業株式会社	２−［［６−［（３ｒ）−３−アミノ−１−ピペリジニル］−３，４−ジヒドロ−３−メチル−２，４−ジオキソ−１（２ｈ）−ピリミジニル］メチル］−４−フルオロベンゾニトリルを含む固形製剤
RU2470635C2 (ru) *	2007-05-11	2012-12-27	Сантен Фармасьютикал Ко., Лтд.	Профилактическое или терапевтическое средство, применяемое при заболеваниях заднего отдела глаза
TW200924768A (en)	2007-10-12	2009-06-16	Astrazeneca Ab	Composition
JP5463564B2 (ja) *	2009-05-22	2014-04-09	国立大学法人信州大学	耐熱性及び耐塩性セルラーゼ製剤
TR201000948A1 (tr)	2010-02-09	2011-08-22	Sanovel İlaç San.Ve Ti̇c.A.Ş.	Aripiprazol formülasyonları.
TWI636784B (zh) *	2011-04-05	2018-10-01	大塚製藥股份有限公司	含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途
US9839684B2 (en)	2011-04-06	2017-12-12	Biovaxim Limited	Pharmaceutical compositions comprising inactivated HIV viral particles and non-pathogenic lactobacilli for the induction of antigen-specific immunotolerance
JO3753B1 (ar) *	2011-10-14	2021-01-31	Otsuka Pharma Co Ltd	قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه

2012
- 2012-10-04 JO JOP/2012/0301A patent/JO3753B1/ar active
- 2012-10-09 TW TW101137267A patent/TWI634908B/zh active
- 2012-10-12 MY MYPI2014700632A patent/MY173370A/en unknown
- 2012-10-12 SI SI201231718T patent/SI2767285T2/sl unknown
- 2012-10-12 AP AP2014007564A patent/AP2014007564A0/xx unknown
- 2012-10-12 PT PT128400256T patent/PT2767285T/pt unknown
- 2012-10-12 EP EP12840025.6A patent/EP2767285B2/en active Active
- 2012-10-12 CN CN201280050586.1A patent/CN103889425B/zh active Active
- 2012-10-12 US US14/351,325 patent/US20140234417A1/en not_active Abandoned
- 2012-10-12 AR ARP120103801A patent/AR088319A1/es not_active Application Discontinuation
- 2012-10-12 ES ES12840025T patent/ES2762479T5/es active Active
- 2012-10-12 CN CN201710266863.7A patent/CN107397730A/zh active Pending
- 2012-10-12 WO PCT/JP2012/076415 patent/WO2013054872A1/ja not_active Ceased
- 2012-10-12 HR HRP20200037TT patent/HRP20200037T4/hr unknown
- 2012-10-12 FI FIEP12840025.6T patent/FI2767285T4/fi active
- 2012-10-12 LT LTEP12840025.6T patent/LT2767285T/lt unknown
- 2012-10-12 EA EA201490783A patent/EA032930B1/ru active Protection Beyond IP Right Term
- 2012-10-12 PL PL12840025.6T patent/PL2767285T5/pl unknown
- 2012-10-12 BR BR112014008603A patent/BR112014008603A2/pt not_active Application Discontinuation
- 2012-10-12 JP JP2013538582A patent/JP6084161B2/ja active Active
- 2012-10-12 DK DK12840025.6T patent/DK2767285T4/da active
- 2012-10-12 PH PH1/2014/500607A patent/PH12014500607A1/en unknown
- 2012-10-12 KR KR1020147010656A patent/KR102072371B1/ko active Active
- 2012-10-12 HU HUE12840025A patent/HUE047493T2/hu unknown
- 2012-10-12 SG SG2014013783A patent/SG2014013783A/en unknown
- 2012-10-12 SG SG10201608412SA patent/SG10201608412SA/en unknown
- 2012-10-12 CA CA2851588A patent/CA2851588C/en active Active
- 2012-10-12 AU AU2012321723A patent/AU2012321723C1/en active Active
- 2012-10-12 UA UAA201405029A patent/UA114411C2/uk unknown
- 2012-10-12 MX MX2014004135A patent/MX376092B/es active IP Right Grant
2014
- 2014-03-13 IL IL231513A patent/IL231513B/en active IP Right Grant
- 2014-03-19 IN IN2055DEN2014 patent/IN2014DN02055A/en unknown
- 2014-03-28 ZA ZA2014/02333A patent/ZA201402333B/en unknown
- 2014-04-10 CL CL2014000909A patent/CL2014000909A1/es unknown
- 2014-05-07 CO CO14098041A patent/CO6950480A2/es unknown
2016
- 2016-02-09 US US15/019,874 patent/US20160158227A1/en not_active Abandoned
2017
- 2017-01-20 JP JP2017008854A patent/JP2017088610A/ja active Pending
- 2017-02-27 US US15/444,113 patent/US20170165258A1/en not_active Abandoned
- 2017-09-22 US US15/713,427 patent/US10307419B2/en active Active
2019
- 2019-04-12 US US16/383,488 patent/US20190240215A1/en not_active Abandoned
2020
- 2020-01-08 CY CY20201100009T patent/CY1122460T1/el unknown
- 2020-10-01 US US17/061,394 patent/US20210023078A1/en not_active Abandoned
2022
- 2022-03-07 US US17/653,838 patent/US20220331311A1/en not_active Abandoned
2023
- 2023-12-18 US US18/543,053 patent/US20240277703A1/en active Pending

Also Published As

Publication number	Publication date
US20140234417A1 (en)	2014-08-21
KR102072371B1 (ko)	2020-02-03
DK2767285T3 (da)	2020-01-27
CA2851588A1 (en)	2013-04-18
NZ622639A (en)	2015-11-27
MY173370A (en)	2020-01-21
EP2767285B2 (en)	2025-02-19
EA201490783A1 (ru)	2014-07-30
WO2013054872A1 (ja)	2013-04-18
LT2767285T (lt)	2020-02-10
IN2014DN02055A (es)	2015-05-15
US20210023078A1 (en)	2021-01-28
US20220331311A1 (en)	2022-10-20
TW201318651A (zh)	2013-05-16
CN103889425B (zh)	2018-08-03
UA114411C2 (uk)	2017-06-12
US20240277703A1 (en)	2024-08-22
US10307419B2 (en)	2019-06-04
JP2017088610A (ja)	2017-05-25
MX2014004135A (es)	2014-07-24
EP2767285A4 (en)	2015-03-11
ZA201402333B (en)	2015-07-29
EP2767285B1 (en)	2019-11-27
US20180008600A1 (en)	2018-01-11
HRP20200037T4 (hr)	2025-05-23
SG2014013783A (en)	2014-06-27
SI2767285T1 (sl)	2020-03-31
SG10201608412SA (en)	2016-12-29
CO6950480A2 (es)	2014-05-20
US20190240215A1 (en)	2019-08-08
AU2012321723C1 (en)	2017-11-02
US20170165258A1 (en)	2017-06-15
IL231513A0 (en)	2014-04-30
JP6084161B2 (ja)	2017-02-22
CL2014000909A1 (es)	2014-11-21
CA2851588C (en)	2019-07-02
CN107397730A (zh)	2017-11-28
EA032930B1 (ru)	2019-08-30
AU2012321723A1 (en)	2014-05-15
ES2762479T5 (en)	2025-05-30
SI2767285T2 (sl)	2025-06-30
IL231513B (en)	2020-01-30
AU2012321723B2 (en)	2017-07-20
BR112014008603A2 (pt)	2017-04-18
US20160158227A1 (en)	2016-06-09
HUE047493T2 (hu)	2020-04-28
DK2767285T4 (da)	2025-04-22
MX376092B (es)	2025-03-07
TWI634908B (zh)	2018-09-11
HRP20200037T1 (hr)	2020-03-20
JPWO2013054872A1 (ja)	2015-03-30
FI2767285T4 (fi)	2025-05-08
PL2767285T3 (pl)	2020-04-30
KR20140075754A (ko)	2014-06-19
EP2767285A1 (en)	2014-08-20
PL2767285T5 (pl)	2025-06-02
PH12014500607A1 (en)	2014-04-21
ES2762479T3 (es)	2020-05-25
CY1122460T1 (el)	2021-01-27
JO3753B1 (ar)	2021-01-31
PT2767285T (pt)	2020-01-21
AR088319A1 (es)	2014-05-28
CN103889425A (zh)	2014-06-25

Publication	Publication Date	Title
AP2014007564A0 (en)	2014-04-30	Tablet comprising 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one or a salt therefor
EP2742497A4 (en)	2015-03-11	PROXIMITY LABEL
GB201113478D0 (en)	2011-09-21	Sensing systems
IL229963A (en)	2017-03-30	Converted quinolines and their use as drugs
EP2751708A4 (en)	2015-11-11	PROVIDE UPDATED INFORMATION
GB2494890B (en)	2015-09-30	Inventorying transponders
SG11201501689RA (en)	2015-04-29	Toughening masterblends
EP2653006A4 (en)	2017-08-09	Wireless sensor network information swarming
LU91843B1 (en)	2013-01-21	Plural-frequency capacitive occupancy sensing system
GB201506841D0 (en)	2015-06-03	A centralisation system
PT2575503E (pt)	2014-07-25	Produto compreendendo catequinas
GB201108356D0 (en)	2011-06-29	Event identification
GB201109593D0 (en)	2011-07-20	System information cachw
EP2762479A4 (en)	2015-04-22	OXAZOLIDINONE ANTIBACTERIAL MEDICINE BASED ON BIARYLIC HETEROCYCLE SUBSTITUTED
GB201219102D0 (en)	2012-12-05	In-memory continuous data protection
HUE12715191T1 (hu)	2016-04-28	Szinterelt üvegtermék
GB2492816B (en)	2017-09-27	Medicines spoon
AU338686S (en)	2011-09-28	Cardigan
AU337630S (en)	2011-07-13	Cardigan
AU338175S (en)	2011-08-19	Cardigan
GB201105845D0 (en)	2011-05-18	New pocket
GB201103031D0 (en)	2011-04-06	Communication alert
GB201204738D0 (en)	2012-05-02	New spoon
GB201108458D0 (en)	2011-07-06	Card protector
GB201119961D0 (en)	2012-01-04	Antibacterial derivatives